Younger people with dementia are more likely to experience quicker disease decline. But annual NDIS reviews don’t capture their changing needs.
If so, it’s just one lifestyle risk among many others.
Alzheimer’s disease is the most common form of dementia. Despite all efforts, no treatments have been found yet. To increase the odds, we need to rethink our approach and try to better understand it.
After the failure of multiple drug trials the outlook for an Alzheimer’s drug is bleak. This shouldn’t be a surprise. We don’t know the cause or even how to diagnose the disease.
Alzheimer’s disease affects many people under the age of 65. The ‘young-onset’ version of the disease is often misdiagnosed as depression or dismissed as a midlife crisis.